Women’s Health

Emzahh Gets FDA Approval for Pregnancy Prevention

Emzahh is an AB-rated generic equivalent of Ortho Micronor.

Reforming Institutions, Integrating Health Technology to Address Maternal Mortality Gap

Experts discuss strategies to reduce the maternal mortality gap by implementing implicit bias training and reevaluating clinical guidelines and algorithms.

FDA Allows Certified Retail Pharmacies to Dispense Mifepristone

Mifepristone is a progestin antagonist indicated, in a regimen with misoprostol, for the medical termination of intrauterine pregnancy through 70 days gestation.

Maternal Mortality Crisis Among Minority Patients in the US

ACOG experts provide actionable steps to reduce the maternal mortality crisis in the US, particularly among minority populations.

HCPs May Not Fully Investigate Heavy Menstrual Bleeding Among Women and Girls

Researchers sought to investigate whether health care providers investigated heavy menstrual bleeding as a potential symptom of an underlying bleeding disorder.

FDA Approves Brexafemme for Recurrent Vulvovaginal Candidiasis

Brexafemme is an oral antifungal agent representing a novel therapeutic class of structurally-distinct glucan synthase inhibitors known as triterpenoids.

High Incidence of Anticoagulation-Associated Abnormal Menstrual Bleeding in Women After Venous Thromboembolism

Researchers sought to determine whether there was a link between abnormal menstrual bleeding and treatment with anticoagulants for VTE.

Liletta Approved for Pregnancy Prevention for Up to 8 Years

The approval was based on additional efficacy data from the ACCESS IUS trial.

Case Study: 2-Rod Subdermal Contraceptive Implant in a Recent Immigrant

Case involving a 2-rod subdermal contraceptive implant mistaken for a 1-rod device demonstrates the importance of delivering culturally competent care.

Antidepressant Use in Pregnancy Underused: Provider and Patient Perspectives

Authors describe the perspectives of patients and prescribing clinicians regarding the use of antidepressants during pregnancy.

FDA Panel Recommends Makena Be Withdrawn From the Market

The product was granted approval through the accelerated approval pathway in 2011.

Awareness, Targeted Contraceptive Counselling Needed in Early Breast Cancer

Researchers explored the fertility, contraception, and reproductive health care needs of premenopausal women with early stage breast cancer.

HDL Is Not Always Good Cholesterol During Menopause Transition

Data from the large-scale SWAN study suggest a rethinking of HDL as beneficial for women in late perimenopause and postmenopause.

Diet Contributes to Menstrual Pain in Teens

Researcher identifies inflammatory foods linked to menstrual pain in teenagers.

Vaginal pH Modulator Misses Primary Endpoint in STI Clinical Trial

Topline results were announced from a phase 3 trial evaluating EVO100 for the prevention of chlamydia and gonorrhea infection in women.

Early Natural Menopause Is a Risk Factor for Lung Diseases in Women Who Smoke

How does early natural menopause affect lung health, aging, and mortality in women who smoke?

Tadalafil May Ease Voiding Problems in Women

In a small study, tadalafil, a PDE5 inhibitor used to treated erectile dysfunction, significantly decreased opening urethral pressure in healthy women.

Fezolinetant NDA Accepted for Vasomotor Symptoms Associated With Menopause

Fezolinetant is an investigational, nonhormonal selective neurokinin-3 receptor antagonist.

Mirena Approved for Pregnancy Prevention for Up to 8 Years

By the end of the 8th year, Mirena should be removed and replaced at the time of removal with a new system if continued use is desired.

Does Endometriosis Up Risk for Stroke in Women Later in Life?

Researchers sought to investigate the association between women with laparoscopically confirmed endometriosis and the risk for stroke.